rs1131690938
Positions:
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM1PM2PP5
The NM_000455.5(STK11):c.481A>T(p.Ile161Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: not found (cov: 33)
Consequence
STK11
NM_000455.5 missense
NM_000455.5 missense
Scores
2
7
10
Clinical Significance
Conservation
PhyloP100: 1.32
Genes affected
STK11 (HGNC:11389): (serine/threonine kinase 11) The protein encoded by this gene is a serine/threonine kinase that regulates cell polarity and energy metabolism and functions as a tumor suppressor. Mutations in this gene have been associated with the autosomal dominant Peutz-Jeghers syndrome, as well as with skin, pancreatic, and testicular cancers. [provided by RefSeq, May 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 5 ACMG points.
PM1
In a domain Protein kinase (size 260) in uniprot entity STK11_HUMAN there are 19 pathogenic changes around while only 5 benign (79%) in NM_000455.5
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 19-1220389-A-T is Pathogenic according to our data. Variant chr19-1220389-A-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 428774.We mark this variant Likely_pathogenic, oryginal submissions are: {Uncertain_significance=1, Likely_pathogenic=2}.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
STK11 | NM_000455.5 | c.481A>T | p.Ile161Phe | missense_variant | 4/10 | ENST00000326873.12 | NP_000446.1 | |
STK11 | NM_001407255.1 | c.481A>T | p.Ile161Phe | missense_variant | 4/9 | NP_001394184.1 | ||
STK11 | NR_176325.1 | n.1748A>T | non_coding_transcript_exon_variant | 5/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
STK11 | ENST00000326873.12 | c.481A>T | p.Ile161Phe | missense_variant | 4/10 | 1 | NM_000455.5 | ENSP00000324856.6 | ||
STK11 | ENST00000652231.1 | c.481A>T | p.Ile161Phe | missense_variant | 4/9 | ENSP00000498804.1 | ||||
STK11 | ENST00000585748.3 | c.109A>T | p.Ile37Phe | missense_variant | 6/12 | 3 | ENSP00000477641.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome Cov.: 32
GnomAD4 exome
Cov.:
32
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:2Uncertain:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Sep 19, 2017 | This variant is denoted STK11 c.481A>T at the cDNA level, p.Ile161Phe (I161F) at the protein level,and results in the change of an Isoleucine to a Phenylalanine (ATT>TTT). This variant has been observed in at leastone family meeting clinical diagnostic criteria of Peutz-Jeghers Syndrome (Borun 2013). STK11 Ile161Phe was notobserved in large population cohorts (NHLBI Exome Sequencing Project, The 1000 Genomes Consortium 2015, Lek2016). Since Isoleucine and Phenylalanine share similar properties, this is considered a conservative amino acidsubstitution. STK11 Ile161Phe occurs at a position where amino acids with properties similar to Isoleucine aretolerated across species and is located within the Protein kinase domain (UniProt). In silico analyses are inconsistentregarding the effect this variant may have on protein structure and function. Based on the currently available evidenceand internal data, we consider STK11 Ile161Phe to be a likely pathogenic variant - |
Peutz-Jeghers syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 15, 2021 | - - |
Hereditary cancer-predisposing syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 08, 2016 | The p.I161F variant (also known as c.481A>T), located in coding exon 4 of the STK11 gene, results from an A to T substitution at nucleotide position 481. The isoleucine at codon 161 is replaced by phenylalanine, an amino acid with highly similar properties. This alteration was detected in one patient meeting diagnostic criteria for Peutz-Jeghers syndrome (PJS), however clinical details were limited (Borun P et al. BMC Med. Genet., 2013 May;14:58). This variant was not reported in population based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), NHLBI Exome Sequencing Project (ESP), and 1000 Genomes Project. In the ESP, this variant was not observed in 6316 samples (12632 alleles) with coverage at this position. To date, this alteration has been detected with an allele frequency of approximately 0.001% (greater than 125000 alleles tested) in our clinical cohort. This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Uncertain
D;D;D
M_CAP
Pathogenic
D
MetaRNN
Uncertain
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;L;.
PrimateAI
Benign
T
PROVEAN
Uncertain
.;D;.
REVEL
Uncertain
Sift
Uncertain
.;D;.
Sift4G
Benign
T;T;D
Polyphen
0.54
.;P;.
Vest4
MutPred
Loss of stability (P = 0.1151);Loss of stability (P = 0.1151);.;
MVP
MPC
2.1
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at